Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 30, 2005

View Archived Issues

Role of voltage-gated sodium channel subtypes in pain processing

Series B financing closed at Protez

GSK exercises option for codevelopment of HGS-ETR1

Concerta approved in Canada for adolescents with ADHD

New insight into cardiovascular actions of anandamide

Antipsychotic drug-induced prefrontal cortical dopamine release potentiated by valproic acid

Anti-CD69 MAb: A novel approach to cancer immunotherapy

Updated data on phase Ib study of CA4P combination therapy

Stem Cell Therapeutics retains Medicon for phase I trial of NTx-265

TQ-1017 receives orphan drug designation for postherpetic neuralgia

DOV suspends dosing in phase III trial of ocinaplon

Eisai and BioArctic Neuroscience form alliance for Alzheimer's immunotherapy

Priority review for Femara sNDA

New phase II study assesses WF-10 as adjuvant treatment for pancreatic cancer

Iclaprim granted fast track designation for cSSSI

Novel Merck HIV integrase inhibitor displays good PK profile across species

Alnylam's siRNA duplexes silence gene involved in hypercholesterolemia

Kinesin-like spindle protein -- a new target for cancer drug design

First selective 5-HT6 agonist described by Wyeth

A-784168: Novel TRPV1 receptor antagonist with antinociceptive activity in vivo

Oral REN-1654 induces modest improvements in pain scores of sciatica patients

Promising phase II data reported for eritoran in severe sepsis

Phase IIa data on the antiviral efficacy of PA-457 in HIV-infected patients

Novel agents for diabetes and related complications reported in recent patent literature

Novel therapeutics for hepatitis C virus infection reported

Novel therapeutics for cardiovascular diseases revealed

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...